Evidence map›Paper›PMID 33967049›Full record

Trial reportJournal of Alzheimer's disease : JAD2021

A Novel Cognitive Function Scale Using Functional Near-Infrared Spectroscopy for Evaluating Cognitive Dysfunction.

Shin Nakamura, Satoshi Yomota, Hitomi Ito, Nobuyuki Akinaga, Ayaka Hori, Kenta Chinomi, Hideaki Suzuki, Kazuhiko Uchida, Takashi Asada

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of Alzheimer's disease : JAD, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shin NakamuraAnalytical & Measuring Instruments Division, Shimadzu Corp., Kyoto, Japan.
Satoshi YomotaAnalytical & Measuring Instruments Division, Shimadzu Corp., Kyoto, Japan.
Hitomi ItoResearch Division, MCBI Inc., Ibaraki, Japan.
Nobuyuki AkinagaAnalytical & Measuring Instruments Division, Shimadzu Corp., Kyoto, Japan.
Ayaka HoriAnalytical & Measuring Instruments Division, Shimadzu Corp., Kyoto, Japan.
Kenta ChinomiTechnology Research Laboratory, Shimadzu Corp., Kyoto, Japan.
Hideaki SuzukiResearch Division, MCBI Inc., Ibaraki, Japan.
Kazuhiko UchidaResearch Division, MCBI Inc., Ibaraki, Japan.
Takashi AsadaMedical Corporation Association Sochikai, Memory Clinic Ochanomizu, Tokyo, Japan.
Shimadzu (Japan) · JPUniversity of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMaintaining cognitive function is integral to a healthy social life in the aged. Although neuropsychological tests and brain imaging methods can assess cognitive dysfunction, these techniques are subjective, psychologically burdensome, and cannot be conducted easily.

objectiveWe sought to develop an objective, low-burden novel cognitive function scale based on functional near-infrared spectroscopy (fNIRS) of hemodynamic changes in the cerebral cortex during daily task performance.

methodsA total of 63 participants (aged 60-80 years) identified as non-dementia controls (NDC) or with mild cognitive impairment (MCI) were recruited and randomly assigned to training and test data sets. Explanatory variables were hemodynamic responses during low-burden sensory and simple tasks without higher-order brain functioning.

resultsA logistic regression analysis of the fNIRS index in NDCs and MCI patients revealed area under the curve, sensitivity, specificity, and holdout results of 0.98, 94%, 88%, and 62% respectively. Correlation between fNIRS index and MCI odds showed positive linearity (R2 = 0.96).

conclusionPositive correlation between the fNIRS index and MCI odds indicated effectiveness of this fNIRS measurement. Although additional experiments are necessary, the fNIRS index representing degree of cognitive decline can be an onsite monitoring tool to assess cognitive status.

Indexed as

AgedAged, 80 and overBrainCerebrovascular CirculationCognitionCognitive DysfunctionFemaleFunctional NeuroimagingHemodynamicsHumansMaleMemory, Short-TermMiddle AgedNeuropsychological TestsSpectroscopy, Near-InfraredCognitive dysfunctionfunctional neuroimagingmental status and dementia testsneuropsychological testsneurovascular couplingspectroscopy near-infrared

Identifiers

PMID33967049
PMCPMC8293658
OpenAlexW3159553680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.